vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v11i1.128vsp-506Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESСЕРОЛОГИЧЕСКИЕ МАРКЕРЫ ЦЕЛИАКИИ И АНТИГЕНЫ HLA КЛАССА II У ДЕТЕЙ И ПОДРОСТКОВ С САХАРНЫМ ДИАБЕТОМ 1 ТИПАSEROLOGICAL MARKERS OF CELIAC DISEASE AND HLA II ANTIGENS IN CHILDREN AND ADOLESCENTS WITH DIABETES MELLITUS TYPE 1ХеннессиЕ. О.HennesyE. O.

Хеннесси Елена Олеговна, аспирант Института детской эндокринологии ФГБУ «Эндокринологический научный центр» Минздравсоцразвития

Адрес: 117036, Москва, ул. Дмитрия Ульянова, д. 11, тел.: (495) 124-02-66, е-mail: eohennessy@gmail.com, libr@endocrincentr.ru

postgraduate student of the Institute of Child Endocrinology of FSBI “Endocrinologic Scientific Center”

eohennessy@gmail.comКураеваТ. Л.KuraevaT. L.eohennessy@gmail.comПрокофьевС. А.ProkofyevS. A.eohennessy@gmail.comСмирноваН. Б.SmirnovaN. B.eohennessy@gmail.comТишинаЮ. В.TishinaY. V.eohennessy@gmail.comТитовичЕ. В.ТitovicE. V.eohennessy@gmail.comПетерковаВ. А.PeterkovaV. A.eohennessy@gmail.comЭндокринологический научный центр, МоскваРоссияScientific Endocrinological Centre, MoscowRussian Federation201215012012111Вопросы современной педиатрии1417Copyright © Хеннесси Е.О., Кураева Т.Л., Прокофьев С.А., Смирнова Н.Б., Тишина Ю.В., Титович Е.В., Петеркова В.А., 20122012Хеннесси Е.О., Кураева Т.Л., Прокофьев С.А., Смирнова Н.Б., Тишина Ю.В., Титович Е.В., Петеркова В.А.Hennesy E.O., Kuraeva T.L., Prokofyev S.A., Smirnova N.B., Tishina Y.V., Тitovic E.V., Peterkova V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/506сахарный диабет 1 типацелиакияHLAаутоиммунные болезниdiabetes mellitus typeIceliac diseaseHLAautoimmune disordersReferences. Todd J. A., Bell J. I., Mc Devitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus // Nature. — 1987; 329 (6140): 599–604.. Todd J. A., Bell J. I., Mc Devitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus // Nature. — 1987; 329 (6140): 599–604.Ploski R., Ek J., Thorsby E., Sollid L. M. On the HLA-DQ (_1*0501, _1*0201) — associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201 // Tissue Antigens. — 1993; 41: 173–177.Ploski R., Ek J., Thorsby E., Sollid L. M. On the HLA-DQ (_1*0501, _1*0201) — associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201 // Tissue Antigens. — 1993; 41: 173–177.Saukkonen T., Savilahti E., Reijonen H. et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus // Diabet. Med. — 1996; 13: 464–470.Saukkonen T., Savilahti E., Reijonen H. et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus // Diabet. Med. — 1996; 13: 464–470.Каspers K., Kordonoiri O., Schober E. Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter survey // J. Pediatr. — 2004; 145: 790–795.Каspers K., Kordonoiri O., Schober E. Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter survey // J. Pediatr. — 2004; 145: 790–795.Barera G., Bonfanti R., Viscardi M. et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study // Pediatrics. — 2002; 109: 833–838.Barera G., Bonfanti R., Viscardi M. et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study // Pediatrics. — 2002; 109: 833–838.Peretti N., Bienvenu F., Bouvet C. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening // Pediatrics. — 2004; 113: 418–422.Peretti N., Bienvenu F., Bouvet C. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening // Pediatrics. — 2004; 113: 418–422.Ricardo A. Caicedo, Ivor D. H. Current Guidelines for the Diagnosis and. Treatment of Celiac Disease // Pediatr Adolesc Med. Basel, Karger. — 2008; 12: 107–113.Ricardo A. Caicedo, Ivor D. H. Current Guidelines for the Diagnosis and. Treatment of Celiac Disease // Pediatr Adolesc Med. Basel, Karger. — 2008; 12: 107–113.National Institutes of Health Consensus Development Conference statement on celiac disease // Gastroenterology. — 2004; 128: 51–89.National Institutes of Health Consensus Development Conference statement on celiac disease // Gastroenterology. — 2004; 128: 51–89.Cranney A., Rostom A., Sy R. et al. // Gastroenterology. — 2005; 128: S109–120.Cranney A., Rostom A., Sy R. et al. // Gastroenterology. — 2005; 128: S109–120.American Gastroenterological Association Institute medical position statement of the diagnosis and management of celiac disease // Gastroenterology. — 2006; 131: 1977–1980.American Gastroenterological Association Institute medical position statement of the diagnosis and management of celiac disease // Gastroenterology. — 2006; 131: 1977–1980.Calero P., Ribes-Koninckx C., Albiach V. et al. IgA antigliadin antibodies as a screening method for nonovert celiac disease in children with insulin-dependent diabetes mellitus // J. Pediatr Gastroenterol Nutr. — 1996; 23: 29–33.Calero P., Ribes-Koninckx C., Albiach V. et al. IgA antigliadin antibodies as a screening method for nonovert celiac disease in children with insulin-dependent diabetes mellitus // J. Pediatr Gastroenterol Nutr. — 1996; 23: 29–33.Kordonouri O., Dieterich W., Schuppan D. et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus // Diabet. Med. — 2000; 17: 441–444.Kordonouri O., Dieterich W., Schuppan D. et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus // Diabet. Med. — 2000; 17: 441–444.Gasbarrini A., Sanz Torre E., Trivellini C. et al. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease // Lancet. — 2000; 256: 399–400.Gasbarrini A., Sanz Torre E., Trivellini C. et al. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease // Lancet. — 2000; 256: 399–400.Mora S., Barera G., Beccio S. et al. A prospective, longitudinal study of long term effect of treatment on bone density in children with celiac disease // J. Pediatr. — 2001; 139: 516–521.Mora S., Barera G., Beccio S. et al. A prospective, longitudinal study of long term effect of treatment on bone density in children with celiac disease // J. Pediatr. — 2001; 139: 516–521.Иванова О.Н., Бардымова Т.П., Прокофьев С.А. и др. Материалы сборника «Медико-биологические аспекты мультифакториальной патологии». — 2006; 1: 512–514.Иванова О.Н., Бардымова Т.П., Прокофьев С.А. и др. Материалы сборника «Медико-биологические аспекты мультифакториальной патологии». — 2006; 1: 512–514.Not T., Tommasini A., Tonini G. et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus // Diabetologia. — 2001; 44 (2): 151–155.Not T., Tommasini A., Tonini G. et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus // Diabetologia. — 2001; 44 (2): 151–155.Cronin C.C., Shanahan F. Insulin-dependent diabetes mellitus and celiac disease // Lancet. — 1997; 349: 1096–1097.Cronin C.C., Shanahan F. Insulin-dependent diabetes mellitus and celiac disease // Lancet. — 1997; 349: 1096–1097.Lepore L., Martelossi S., Pennesi M. et al. Prevalence of celiac disease in patients with juvenile chronic arthritis // J. Pediatr. — 1996 Aug; 129 (2): 311–3.Lepore L., Martelossi S., Pennesi M. et al. Prevalence of celiac disease in patients with juvenile chronic arthritis // J. Pediatr. — 1996 Aug; 129 (2): 311–3.Corazza G., Andreani M., Venturo N. // Gastroenterology. — 1995; 109: 1333–1337.Corazza G., Andreani M., Venturo N. // Gastroenterology. — 1995; 109: 1333–1337.Collin P., Salmi J., Hallstrom O. et al. Autoimmune thyroid disorders and coeliac disease // Eur J Endocrinol. — 1994; 130 (2): 137–140.Collin P., Salmi J., Hallstrom O. et al. Autoimmune thyroid disorders and coeliac disease // Eur J Endocrinol. — 1994; 130 (2): 137–140.Ventura A., Magazzu G., Greco L. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease // Gastroenterology. — 1999; 117 (2): 297–303.Ventura A., Magazzu G., Greco L. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease // Gastroenterology. — 1999; 117 (2): 297–303.Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder // Nat Rev Immunol. — 2002; 2: 647–655.Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder // Nat Rev Immunol. — 2002; 2: 647–655.Karell H., Louka A.S., Moodie S.J. et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease // Hum Immunol. — 2003; 64: 469–477.Karell H., Louka A.S., Moodie S.J. et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease // Hum Immunol. — 2003; 64: 469–477.Doolan A., Donaghue K., Fairchild J. et al. Use of HLA Typing in Diagnosing Celiac Disease in Patients With Type 1 Diabetes // Diabetes Care. — 2005; 28 (4): 806–809.Doolan A., Donaghue K., Fairchild J. et al. Use of HLA Typing in Diagnosing Celiac Disease in Patients With Type 1 Diabetes // Diabetes Care. — 2005; 28 (4): 806–809.

The authors declare that there are no conflicts of interest present.